17 Aug 2016 Reverse stock splits don't have any impact on a company's value, but they often are a sign of trouble. Genocea Biosciences Stock Split History

6 Top Gainers In Pharma Sector (MRTX, NK, GNCA) RTTNews 304d. Navidea Biopharmaceuticals Announces Reverse Stock Split. Businesswire 349d. In finance, a reverse stock split or reverse split is a process by which shares of corporate stock are effectively merged to form a smaller number of proportionally   iBio (IBIO) Stock Will Not Undergo A Reverse Split · Joshua Rodriguez - March 3, Genocea Biosciences (GNCA) Stock: Cancer Vaccine Data Leads To Gains. 3 Jun 2019 Find reverse split stocks to trade and add to watchlist. Runners like $DMPI and $ GNCA stock were both recent reverse split penny stocks from  21 Jun 2019 Sonoma Pharma reported a 1-for-9 reverse stock split effective at Genocea Biosciences, Inc. (NASDAQ: GNCA) dropped 7.8% to close at  SPNV - Superior Energy Services - had a 1 for 10 reverse split. NAKD - Naked Brand GNCA - Genocea Biosciences - had a 1 for 8 reverse split. 05/21/2019. a 2.832861-for-1 reverse stock split of our common stock and our redeemable of directors of Genocea Biosciences (Nasdaq:GNCA) since February 2018, 

Find the latest Genocea Biosciences, Inc. (GNCA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Genocea Biosciences, Inc. (GNCA) Split History | Seeking Alpha See Genocea Biosciences, Inc. (GNCA) history of stock splits. Includes date and ratio. GNCA - Genocea Biosciences Inc Stock quote - CNNMoney.com Find real-time GNCA - Genocea Biosciences Inc stock quotes, company profile, news and forecasts from CNN Business. GNCA - Genocea Summary, Stock Quote and News | Benzinga Jan 01, 2010 · Genocea (NASDAQ: GNCA) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. Genocea Biosciences, Inc. - GNCA - Stock Price Today - Zacks

GNCA - Genocea Summary, Stock Quote and News | Benzinga

Company profile for Genocea Biosciences (GNCA) including business summary, key statistics, ratios, sector. A stock's Profile page contains general information about the stock, such as Ticker Symbol, Exchange traded on, Company Contact Address/Phone, CEO/President, and Company Description. Most Recent Split: The share split recorded and Current Report Filing (8-k)

GNCA | Complete Genocea Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Genocea Biosciences, Inc. Common Stock (GNCA) Stock Quotes ... Genocea Biosciences, Inc. Common Stock (GNCA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. GNCA Genocea Biosciences — Stock Price and Discussion ... Apr 03, 2020 · Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. What's a Reverse Stock Split, and Can It ... - The Motley Fool The reverse split itself doesn't result in any change in the value of an investor's position in a stock, because the smaller number of post-split shares is offset by the proportionally higher per

Gilead Sciences Stock Split History

Stock split history for Genocea Biosciences since 2020. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see  Split History. Stock splits are used by Genocea Biosciences, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a  

GNCA.OQ - Genocea Biosciences Inc Key Developments | Reuters may 21 (reuters) - genocea biosciences inc ::genocea biosciences inc - filed a certificate of amendment to co's restated certificate of incorporation to effect a reverse stock split Press Releases — Investor Relations — Genocea Biosciences CAMBRIDGE, Mass. , Feb. 26, 2020 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc . (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark , president and chief executive officer, will present a corporate overview at the Cowen GNCA | Stock Snapshot - Fidelity Apr 02, 2020 · Stock quote and company snapshot for GENOCEA BIOSCIENCES INC (GNCA), including profile, stock chart, recent news and events, analyst opinions, and research reports. GNCA: Genocea Biosciences, Inc. - Brokerage ...